Functional characterization of promoter variants of the adiponectin gene complemented by epidemiological data

Diabetes

Volumn 58, Issue 4, 2009, Pages 984-991

  Laumen, Helmut ^a   Saningong, Akuma D ^a   Heid, Iris M ^b,c   Hess, Jochen ^d   Herder, Christian ^e   Claussnitzer, Melina ^a   Baumert, Jens ^b   Lamina, Claudia ^b   Rathmann, Wolfgang ^e   Sedlmeier, Eva Maria ^a   Klopp, Norman ^b   Thorand, Barbara ^b   Wichmann, H Erich ^b,c   Illig, Thomas ^b   Hauner, Hans ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; LUCIFERASE; ROSIGLITAZONE;

ADIPOCYTE; ADULT; AGED; ANIMAL CELL; APM1 GENE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENETIC COMPLEMENTATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; REPORTER GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

3T3 CELLS; ADIPOCYTES; ADIPONECTIN; ADULT; AGED; ALGORITHMS; ANIMALS; CELL LINE; CHROMOSOME MAPPING; CLONING, MOLECULAR; DNA PRIMERS; FEMALE; GENETIC VARIATION; HUMANS; MALE; MICE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; TRANSFECTION;

EID: 64649104152     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db07-1646     Document Type: Article

References (37)

1. Hauner H: Secretory factors from human adipose tissue and their functional role. Proc Nutr Soc 64:163-169, 2005
2. Matsuzawa Y: The metabolic syndrome and adipocytokines. FEBS Lett 580:2917-2921, 2006
3. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941-946, 2001
4. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE: The adipocyte- secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7:947953, 2001
5. Ouedraogo R, Gong Y, Berzins B, Wu X, Mahadev K, Hough K, Chan L, Goldstein BJ, Scalia R: Adiponectin deficiency increases leukocyte-endo- thelium interactions via upregulation of endothelial cell adhesion molecules in vivo. J Clin Invest 117:1718-1726, 2007
6. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K: Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116:1784-1792, 2006
7. Vionnet N, Hani EH, Dupont S, Gallina S, Francke S, Dotte S, De Matos F, Durand E, Lepretre F, Lecoeur C, Gallina P, Zekiri L, Dina C, Froguel P: Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am J Hum Genet 67:1470-1480, 2000
8. Vasseur F, Helbecque N, Dina C, Lobbens S, Delannoy V, Gaget S, Boutin P, Vaxillaire M, Lepretre F, Dupont S, Hara K, Clement K, Bihain B, Kadowaki T, Froguel P: Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte- secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 11:2607-2614, 2002
9. Vasseur F, Helbecque N, Lobbens S, Vasseur-Delannoy V, Dina C, Clement K, Boutin P, Kadowaki T, Scherer PE, Froguel P: Hypoadiponectinaemia and high risk of type 2 diabetes are associated with adiponectin-encoding (ACDC) gene promoter variants in morbid obesity: evidence for a role of ACDC in diabesity. Diabetologia 48:892-899, 2005
10. Heid IM, Wagner SA, Gohlke H, Iglseder B, Mueller JC, Cip P, Ladurner G, Reiter R, Stadlmayr A, Mackevics V, Illig T, Kronenberg F, Paulweber B: Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1,727 healthy Caucasians. Diabetes 55:375-384, 2006
11. Bouatia-Naji N, Meyre D, Lobbens S, Seron K, Fumeron F, Balkau B, Heude B, Jouret B, Scherer PE, Dina C, Weill J, Froguel P: ACDC/adiponectin polymorphisms are associated with severe childhood and adult obesity. Diabetes 55:545-550, 2006
12. Laumen H, Skurk T, Hauner H: The HMG-CoA reductase inhibitor rosuv- astatin inhibits plasminogen activator inhibitor-1 expression and secretion in human adipocytes. Atherosclerosis 196:565-573, 2008
13. Kita A, Yamasaki H, Kuwahara H, Moriuchi A, Fukushima K, Kobayashi M, Fukushima T, Takahashi R, Abiru N, Uotani S, Kawasaki E, Eguchi K: Identification of the promoter region required for human adiponectin gene transcription: association with CCAAT/enhancer binding protein-beta and tumor necrosis factor-alpha. Biochem Biophys Res Comm 331:484-490, 2005
14. Schorpp M, Mattei MG, Herr I, Gack S, Schaper J, Angel P: Structural organization and chromosomal localization of the mouse collagenase type I gene. Biochem J 308:211-217, 1995
15. Loewel H, Doering A, Schneider A, Heier M, Thorand B, Meisinger C: The MONICA Augsburg surveys: basis for prospective cohort studies. Gesund- heitswesen 67:13-18, 2005
16. Rathmann W, Haastert B, Herder C, Hauner H, Koenig W, Meisinger C, Holle R, Giani G: Differential association of adiponectin with cardiovascular risk markers in men and women? The KORA survey 2000. Int J Obes 31:770-776, 2006
17. Herder C, Hauner H, Haastert B, Rohrig K, Koenig W, Kolb H, Muller- Scholze S, Thorand B, Holle R, Rathmann W: Hypoadiponectinemia and proinflammatory state: two sides of the same coin? Results from the Cooperative Health Research in the Region of Augsburg Survey 4 (KORA S4). Diabetes Care 29:1626-1631, 2006
18. Thorand B, Kolb H, Baumert J, Koenig W, Chambless L, Meisinger C, Illig T, Martin S, Herder C: Elevated levels of interleukin-18 predict the development of type 2 diabetes: results from the MONICA/KORA Augsburg Study, 1984-2002. Diabetes 54:2932-2938, 2005
19. Weidinger S, Klopp N, Wagenpfeil S, Rummler L, Schedel M, Kabesch M, Schafer T, Darsow U, Jakob T, Behrendt H, Wichmann HE, Ring J, Illig T:
20. Association of a STAT 6 haplotype with elevated serum IgE levels in a population based cohort of white adults. J Med Genet 41:658-663, 2004
21. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA: Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70:425-434, 2002
22. Tschritter O, Fritsche A, Thamer C, Haap M, Shirkavand F, Rahe S, Staiger H, Maerker E, Haring H, Stumvoll M: Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 52:239-243, 2003
23. Stefan N, Stumvoll M, Vozarova B, Weyer C, Funahashi T, Matsuzawa Y, Bogardus C, Tataranni PA: Plasma adiponectin and endogenous glucose production in humans. Diabetes Care 26:3315-3319, 2003
24. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Ya- mashita S, Hanafusa T, Matsuzawa Y: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterio- scler Thromb Vasc Biol 20:1595-1599, 2000
25. Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, Arita Y, Okamoto Y, Shimomura I, Hiraoka H, Nakamura T, Funahashi T, Matsuzawa Y: Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 23:85-89, 2003
26. Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, Yen FT, Bihain BE, Lodish HF: Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad SciUSA98:2005-2010, 2001
27. Yamamoto Y, Hirose H, Saito I, Tomita M, Taniyama M, Matsubara K, Okazaki Y, Ishii T, Nishikai K, Saruta T: Correlation of the adipocyte- derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci (Lond) 103:137-142, 2002
28. Iwashima Y, Katsuya T, Ishikawa K, Ouchi N, Ohishi M, Sugimoto K, Fu Y, Motone M, Yamamoto K, Matsuo A, Ohashi K, Kihara S, Funahashi T, Rakugi H, Matsuzawa Y, Ogihara T: Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 43:1318-1323, 2004
29. Schwarz PE, Govindarajalu S, Towers W, Schwanebeck U, Fischer S, Vasseur F, Bornstein SR, Schulze J: Haplotypes in the promoter region of the ADIPOQ gene are associated with increased diabetes risk in a German Caucasian population. Horm Metab Res 38:447-451, 2006
30. Qiao L, MacLean PS, Schaack J, Orlicky DJ, Darimont C, Pagliassotti M, Friedman JE, Shao J: C/EBP-alpha regulates human adiponectin gene transcription through an intronic enhancer. Diabetes 54:1744-1754, 2005
31. Kim HB, Kong M, Kim TM, Suh YH, Kim WH, Lim JH, Song JH, Jung MH: NFATc4 and ATF3 negatively regulate adiponectin gene expression in 3T3-L1 adipocytes. Diabetes 55:1342-1352, 2006
32. Iwaki M, Matsuda M, Maeda N, Funahashi T, Matsuzawa Y, Makishima M, Shimomura I: Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 52:1655-1663, 2003
33. Musri MM, Corominola H, Casamitjana R, Gomis R, Parrizas M: Histone H3 lysine 4 dimethylation signals the transcriptional competence of the adiponectin promoter in preadipocytes. J Biol Chem 281:17180-17188, 2006
34. Zhang D, Ma J, Brismar K, Efendic S, Gu HF: A single nucleotide polymorphism alters the sequence of SP1 binding site in the adiponectin promoter region and is associated with diabetic nephropathy among type 1 diabetic patients in the Genetics of Kidneys in Diabetes Study. J Diabetes Complications Epub ahead: doi:10.1016/j.jdiacomp. 2008
35. Gustafson B, Jack MM, Cushman SW, Smith U: Adiponectin gene activation by thiazolidinediones requires PPAR-gamma2, but not C/EBP-alpha: evidence for differential regulation of the aP2 and adiponectin genes. Biochem Biophys Res Comm 308:933-939, 2003
36. Yang WS, Jeng CY, Wu TJ, Tanaka S, Funahashi T, Matsuzawa Y, Wang JP, Chen CL, Tai TY, Chuang LM: Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adi- ponectin in type 2 diabetic patients. Diabetes Care 25:376 -380, 2002
37. Hauner H: The mode of action of thiazolidinediones. Diabete Metab Res Rev 18 (Suppl. 2):10-15, 2002